EUCTR2014-001273-13-FR进行中（未招募）1 期
Clinical trial with somatostatine analog treatment in merkel carcinoma patients.
niversity Hospital of Grenoble0 个研究点开始时间: 2015年8月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Research on the effectiveness of octreotide in Gastric Antral Vascular Ectasia (GAVE)in patients with anemia.Gastric Antral Vascular Ectasia (also known as watermelon stomach)EUCTR2020-004075-41-NLRadboudumc12
招募中
不适用
Effectiveness of Somatostatin Analogues in patients with Gastric Antral Vascular Ectasia and symptomatic gastrointestinal bleeding: SAGAVE Pilot studyNL-OMON21472Radboudumc12
招募中
2 期
Effectiveness of Somatostatin Analogues in patients with Gastric antral vascular ectasia and symptomatic gastrointestinal bleeding: SAGAVE-trial1) Gastric Antral Vascular Ectasia. 2) Watermelon stomach.10017959NL-OMON49336Radboud Universitair Medisch Centrum14
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-NLRadboudumc38
尚未招募
不适用
Onderzoek naar de effectiviteit van octreotide in hereditary hemorrhagic telangiectasia patiënten metdaarbij gastrointestinale bloedingen.NL-OMON25382Radboudumc38